Andrew G. Watts

Andrew G. Watts

Auto-generated profile, based on publicly available information

Andrew G. Watts

University of Bath

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2004 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
CCCecilia P C Chiu
Cecilia P C Chiu
AWAndrew G Watts
Andrew G Watts
LLLuke L Lairson
Luke L Lairson
MGMichel Gilbert
Michel Gilbert
DLDaniel Lim
Daniel Lim
NSNatalie C J Strynadka
Natalie C J Strynadka

5 April 2013 in Science
Verified
Journal Article
Closed access
PDF file
JKJin-Hyo Kim
Jin-Hyo Kim
RRRicardo Resende
Ricardo Resende
TWTom Wennekes
Tom Wennekes
HCHong-Ming Chen
Hong-Ming Chen
NBNicole Bance
Nicole Bance
SWStephen Withers
Stephen Withers
Adding to the Antiviral Arsenal: The envelope of influenza virus contains two immunodominant glycoproteins: hemagglutinin and neuraminidase (NA). Existing antivirals like zanamivir (Relenza) and oseltamivir (Tamiflu) target NA; however, the development of drug resistance is a problem. Kim et al. (p. 71 , published online 21 February) now report a different class of NA inhibitors. NA catalyzes the removal of sialic acids from the surface of host cells to initiate entry. Discovery of a NA–sialic acid intermediate led to the production of sialic acid analogs that bound covalently to NA and inhibited its enzymatic activity. These compounds showed activity against a wide variety of influenza strains, inhibited viral replication in cell culture, and were able to protect mice against influenza infection. Protection of mice was equivalent to protection seen from zanamivir. Moreover, the compounds showed activity against drug-resistant strains in vitro. These compounds represent a potentially useful addition to the arsenal of antivirals used to treat influenza infection.

30 May 2003 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
AWAndrew G. Watts
Andrew G. Watts
IDIben Damager
Iben Damager
MAMaria L. Amaya
Maria L. Amaya
ABAlejandro Buschiazzo
Alejandro Buschiazzo
PAPedro Alzari
Pedro Alzari
SWStephen G. Withers
Stephen G. Withers

1 April 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SNSimon Newstead
Simon Newstead
JPJane A. Potter
Jane A. Potter
JWJennifer C. Wilson
Jennifer C. Wilson
GXGuogang Xu
Guogang Xu
CCChin-Hsiang Chien
Chin-Hsiang Chien
GTGarry L. Taylor
Garry L. Taylor
Clostridium perfringens is a Gram-positive bacterium responsible for bacteremia, gas gangrene, and occasionally food poisoning. Its genome encodes three sialidases, nanH, nanI, and nanJ, that are involved in the removal of sialic acids from a variety of glycoconjugates and that play a role in bacterial nutrition and pathogenesis. Recent studies on trypanosomal (trans-) sialidases have suggested that catalysis in all sialidases may proceed via a covalent intermediate similar to that of other retaining glycosidases. Here we provide further evidence to support this suggestion by reporting the 0.97Å resolution atomic structure of the catalytic domain of the C. perfringens NanI sialidase, and complexes with its substrate sialic acid (N-acetylneuramic acid) also to 0.97Å resolution, with a transition-state analogue (2-deoxy-2,3-dehydro-N-acetylneuraminic acid) to 1.5Å resolution, and with a covalent intermediate formed using a fluorinated sialic acid analogue to 1.2Å resolution. Together, these structures provide high resolution snapshots along the catalytic pathway. The crystal structures suggested that NanI is able to hydrate 2-deoxy-2,3-dehydro-N-acetylneuraminic acid to N-acetylneuramic acid. This was confirmed by NMR, and a mechanism for this activity is suggested.

15 June 2008 in The Journal of Immunology
Verified
Journal Article
Closed access
JHJames Hewinson
James Hewinson
SMSamantha F Moore
Samantha F Moore
CGChristian Glover
Christian Glover
AWAndrew G Watts
Andrew G Watts
AMAmanda B MacKenzie
Amanda B MacKenzie
P2X7 receptors (P2X7Rs) are ATP-gated ion channels that trigger caspase-1 activation in the presence of TLR ligands. Inflammatory caspase-1 is responsible for the proteolytic activation of IL-1β. However, the signaling events that couple P2X7Rs to caspase-1 activation remain undefined. In this study we demonstrate that ATP-induced cellular oxidation is critical for caspase-1 activation and subsequent IL-1β processing. Purinergic receptor stimulation, including P2X7Rs, of endotoxin-primed human monocytes augments NADPH oxidase activity whereas concurrent purinergic receptor stimulation triggers protein denitroyslation, leading to the formation of peroxynitrite. IL-1β cleavage is blocked under conditions where superoxide anion formation is blocked or monocytes are treated with antioxidants or a peroxynitrite scavenger. Nigericin, a K+/H+ antiporter, also increases NADPH oxidase activity, leading to IL-1β and caspase-1 processing that is blocked by a peroxynitrite scavenger or inhibition of NADPH oxidase. These data demonstrate that signaling via NADPH oxidase activity is fundamental for the processing of mature IL-1β induced by P2X7R stimulation.

1 August 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AMAxel Müller
Axel Müller
ESEmmanuele Severi
Emmanuele Severi
CMChristopher Mulligan
Christopher Mulligan
AWAndrew G. Watts
Andrew G. Watts
DKDavid J. Kelly
David J. Kelly
GTGavin H. Thomas
Gavin H. Thomas
Extracytoplasmic solute receptors (ESRs) are important components of solute uptake systems in bacteria, having been studied extensively as parts of ATP binding cassette transporters. Herein we report the first crystal structure of an ESR protein from a functionally characterized electrochemical ion gradient dependent secondary transporter. This protein, SiaP, forms part of a tripartite ATP-independent periplasmic transporter specific for sialic acid in Haemophilus influenzae. Surprisingly, the structure reveals an overall topology similar to ATP binding cassette ESR proteins, which is not apparent from the sequence, demonstrating that primary and secondary transporters can share a common structural component. The structure of SiaP in the presence of the sialic acid analogue 2,3-didehydro-2-deoxy-N-acetylneuraminic acid reveals the ligand bound in a deep cavity with its carboxylate group forming a salt bridge with a highly conserved Arg residue. Sialic acid binding, which obeys simple bimolecular association kinetics as determined by stopped-flow fluorescence spectroscopy, is accompanied by domain closure about a hinge region and the kinking of an alpha-helix hinge component. The structure provides insight into the evolution, mechanism, and substrate specificity of ESR-dependent secondary transporters that are widespread in prokaryotes.